507 related articles for article (PubMed ID: 35171030)
1. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
[TBL] [Abstract][Full Text] [Related]
2. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
[TBL] [Abstract][Full Text] [Related]
3. Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains.
Markusková B; Elnwrani S; Andrezál M; Sedláčková T; Szemes T; Slobodníková L; Kajsik M; Drahovská H
Arch Virol; 2024 Jun; 169(7):142. PubMed ID: 38851653
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of two bacteriophages with lytic activity against multidrug-resistant Escherichia coli.
Fu P; Zhao Q; Shi L; Xiong Q; Ren Z; Xu H; Chai S; Xu Q; Sun X; Sang M
Virus Res; 2021 Jan; 291():198196. PubMed ID: 33098914
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic
Slobodníková L; Markusková B; Kajsík M; Andrezál M; Straka M; Liptáková A; Drahovská H
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372554
[TBL] [Abstract][Full Text] [Related]
6. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
Malik S; Nehra K; Rana JS
Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.
Ramírez-Castillo FY; Moreno-Flores AC; Avelar-González FJ; Márquez-Díaz F; Harel J; Guerrero-Barrera AL
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):34. PubMed ID: 30041652
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of lytic bacteriophages from various sources in Addis Ababa against antimicrobial-resistant diarrheagenic Escherichia coli strains and evaluation of their therapeutic potential.
Sada TS; Tessema TS
BMC Infect Dis; 2024 Mar; 24(1):310. PubMed ID: 38486152
[TBL] [Abstract][Full Text] [Related]
9. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
[TBL] [Abstract][Full Text] [Related]
10. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
Manohar P; Nachimuthu R; Lopes BS
BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
[TBL] [Abstract][Full Text] [Related]
12. Characterization and synergy studies of Caudoviricete Escherichia phage FS2B infecting multi-drug resistant uropathogenic Escherichia coli isolates.
Malik S; Nehra K; Mann A; Jagdish R; Rana JS
Int Microbiol; 2024 Feb; 27(1):155-166. PubMed ID: 37247084
[TBL] [Abstract][Full Text] [Related]
13. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of two novel Escherichia bacteriophages against multiple drug resistant avian pathogenic Escherichia coli.
Karami M; Goudarztalejerdi A; Mohammadzadeh A; Berizi E
BMC Infect Dis; 2024 May; 24(1):497. PubMed ID: 38755537
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophage therapy for
Bhargava K; Nath G; Dhameja N; Kumar R; Aseri GK; Jain N
Future Microbiol; 2023 Apr; 18():323-334. PubMed ID: 37140267
[TBL] [Abstract][Full Text] [Related]
16. Urinary Plasmids Reduce Permissivity to Coliphage Infection.
Montelongo Hernandez C; Putonti C; Wolfe AJ
Microbiol Spectr; 2023 Aug; 11(4):e0130923. PubMed ID: 37409956
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic
Salazar KC; Ma L; Green SI; Zulk JJ; Trautner BW; Ramig RF; Clark JR; Terwilliger AL; Maresso AW
mBio; 2021 Apr; 12(2):. PubMed ID: 33906920
[TBL] [Abstract][Full Text] [Related]
18. Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic
Salamzade R; McElheny CL; Manson AL; Earl AM; Shaikh N; Doi Y
mSphere; 2023 Oct; 8(5):e0018423. PubMed ID: 37581436
[No Abstract] [Full Text] [Related]
19. Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections.
Barros J; Melo LDR; Poeta P; Igrejas G; Ferraz MP; Azeredo J; Monteiro FJ
Int J Antimicrob Agents; 2019 Sep; 54(3):329-337. PubMed ID: 31229670
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of polyvalent bacteriophages infecting multi drug resistant Salmonella serovars isolated from broilers in Egypt.
Mahmoud M; Askora A; Barakat AB; Rabie OE; Hassan SE
Int J Food Microbiol; 2018 Feb; 266():8-13. PubMed ID: 29156244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
